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ABSTRACT: Introduction: The purpose of this study is to pro-
vide a controlled trial looking at the risk of paraspinal hematoma
formation following extensive paraspinal muscle electromyogra-
phy. Methods: 54 subjects ages 55–80 underwent MRI of the
lumbar spine before or shortly after electromyography using the
paraspinal mapping technique. A neuroradiologist, blinded to
the temporal relationship between the EMG and MRI, reviewed
the MRIs to look for hematomas in or around the paraspinal
muscles. Results: Two MRIs demonstrated definite paraspinal
hematomas, while 10 were found to have possible hematomas.
All hematomas were < 15 mm, and none were close to any
neural structures. There was no relationship between MRI evi-
dence of hematoma and either the timing of the EMG or the
use of aspirin or other nonsteroidal anti-inflammatory drugs.
Conclusions: Paraspinal electromyography can be considered
safe in the general population and those taking nonsteroidal
anti-inflammatory drugs.
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The skeletal muscles have a rich vascular supply,
and there are many small or medium sized blood
vessels deep within the paraspinal musculature that
cannot be visualized or palpated easily. Despite
this, no clear case of symptomatic bleeding compli-
cations of standard lumbar paraspinal needle elec-
tromyography (EMG) has been reported. There
are, however, reports in the literature of asymp-
tomatic MRI-confirmed paraspinal hematomas fol-
lowing paraspinal electromyography.1–3 In at least
one of these cases, the patient had suffered a fall
before the MRI, suggesting the possibility that the
hematoma may not have been the direct result of
the electrodiagnostic test.
Patients with bleeding disorders and those on
therapeutic doses of pharmacologic anticoagulants
may be at higher risk for the above-described com-
plications, but the magnitude of this risk is
unknown. Nine percent of 47 EMG laboratories sur-
veyed reported at least 1 severe bleeding complica-
tion in an anticoagulated patient that required
medical or surgical intervention.4 The specific com-
plications were not described, so it is unknown
whether paraspinal needle examination was the cul-
prit. 66% of laboratories surveyed reported that
they were unwilling to perform needle electromyog-
raphy on the paraspinal muscles of anticoagulated
patients.4 The rationale for avoiding the paraspinal
muscles is that they are located at a noncompressi-
ble site, and large hematomas could compromise
adjacent nerve roots or the spinal cord. Practi-
tioners may counsel patients to discontinue anticoa-
gulants before electromyography, thereby increas-
ing the risk of thrombotic complications.5
Before the safety of paraspinal electromyography
in therapeutically anticoagulated patients can be
assessed, it makes sense to establish the extent of
bleeding in low risk patients. If standard electromy-
ography results in frequent asymptomatic paraspinal
hemorrhages, it would be reasonable to speculate
that bleeding complications would be more severe
in an anticoagulated patient population. In a review
of 370 patients who had paraspinal EMG and an
MRI scan within a week, no radiographic evidence
of paraspinal hematoma was identified.6 Although
these results are reassuring, the degree of paraspinal
exploration in the subjects was not standardized. It
is common practice to perform needle electromyog-
raphy on one lumbar paraspinal muscle as part of a
standard electrodiagnostic examination, so it is likely
that the burden of paraspinal needle examination in
the patients in this series was minimal.7
Paraspinal mapping is a needle electromyogra-
phy technique that has been shown to have a high
sensitivity for the diagnosis of clinical lumbar spi-
nal stenosis and lumbar radiculopathy.8–10 This
technique requires needle insertion at multiple lev-
els on both sides of the back. The purpose of our
study was to assess for MRI evidence of paraspinal
hematomas following paraspinal mapping. With
such a high burden of needle exploration, this
technique should give us a sensitive appraisal of
the bleeding risks of paraspinal electromyography.
Important flaws in the past literature are a lack
of masking and a lack of a control population.
Biases can occur. It is important to have a study in
which the examiner of the imaging study is truly
blinded to the condition of the patient.
METHODS
Subjects were selected based on participation in
the NIH funded Michigan Spinal Stenosis Study
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and Michigan Spinal Stenosis Study II (Haig AJ,
Principle Investigator, Paraspinal Denervation in
Low Back Pain. R01HD052959 and 5 R01
NS41855-02, from the Eunice Kennedy Shriver
National Institute of Child Health & Human De-
velopment.) The study was approved by the institu-
tional review board, and a signed informed con-
sent was obtained from each subject before
participation in the study. Subjects recruited for
the study included those with clinical lumbosacral
spinal stenosis and asymptomatic controls, ages
55–80. Some of the subjects were taking aspirin or
other nonsteroidal anti-inflammatory drugs, but
none were being treated with oral or parenteral
anticoagulation. All subjects underwent nerve con-
duction studies and needle electromyography
including the standardized paraspinal mapping
protocol. All EMG studies were performed and
interpreted by physiatrists or neurologists with
board certification in electrodiagnostic medicine.
A 50- to 75-mm monopolar needle was inserted at
each of 4 sites (L2, L3, L4, and L5) with 3 differ-
ent orientations. The needle was inserted at
approximately 5 mm increments from the most su-
perficial aspect of the muscle to the spinous pro-
cess or the hub of the needle.8
All subjects were imaged on a 1.5 Tesla (T) MRI
scanner (GE Signa or Siemons Acheiva) including
sagittal T1-weighted, T2-weighted, fat-suppressed T2-
weighted (‘‘STIR’’), and axial T1-weighted and T2-
weighted scans through the lumbosacral spinal
region. Axial T2-weighted scans were angled
through individual intervertebral discs. Axial T1-
weighted scans were obtained as contiguous sections
oriented perpendicular to the long axis of the spine.
All sagittal scans and the axial T1-weighted scans
were performed with 4-mm-thick sections with a 1-
mm ‘‘gap.’’ No contrast enhanced scans were
obtained. For several patients, outside institution
studies were used if at least T1-weighted and T2-
weighted scans in at least 2 planes were supplied.
Some subjects underwent MRI scanning before
EMG, and some afterward. The MRI scans were
reviewed by a neuroradiologist who was blinded to
the temporal relationship between the EMG and
MRI. The neuroradiologist was asked to comment
on the presence, size, and location of any hemato-
mas in or around the paraspinal muscles. To be con-
sidered a hematoma, a lesion was required to be > 2
mm in size and visible on more than one imaging
sequence and in more than one plane. Lesions were
considered definite hematomas if they were isoin-
tense/hyperintense to muscle on T1-weighted scans
and hyperintense on T2-weighted scans, with a he-
mosiderin rim (dark on T2-weighted scans).
Lesions located immediately behind and contig-
uous with facet joints were considered possible
hematomas, as such lesions may also represent sy-
novial cysts arising from degenerative facet joints.
Hemorrhage within synovial cysts is a known phe-
nomenon, and the MR imaging characteristics of a
hemorrhagic synovial cyst would be identical to
those of a posttraumatic hematoma. Even a nonhe-
morrhagic cyst with synovial joint proteinaceous
fluid extending from the facet joint may be diffi-
cult to distinguish from a hematoma, although the
latter would be expected to eventually develop a
hemosiderin rim. Therefore, we considered a
lesion to be a definite hematoma only if the lesion
demonstrated both fluid signal consistent with
blood products and a hemosiderin rim. In the ab-
sence of a hemosiderin rim, lesions were only con-
sidered to be possible hematomas (Fig. 1)11
When a possible hematoma was discovered in a
previously symptomatic subject, a chart review was
performed to look for clinic notes or phone notes
FIGURE 1. (1) Definite hematoma. Sagittal T1-weighted (a) and axial T2-weighted (b) MR scans through the lower lumbar spine dem-
onstrate a 4  4  8 mm T1 isointense and T2 hyperintense lesion with a hypointense rim (arrow) located behind the right L4 lamina
at the L5 level; imaging characteristics are consistent with old blood products (proteinaceous fluid) with a rim of hemosiderin staining.
(2) Possible hematoma. Sagittal T1-weighted (a) and sagittal (b) and axial (c)T2-weighted MR scans through the lower lumbar spine
demonstrate a 5 mm T1 isointense and T2 hyperintense lesion (arrow) located in the immediate left paraspinous region at the L4 level;
imaging characteristics are consistent with complex chronic fluid collection.
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suggesting that the subject had reported new back
pain, radicular pain, limb numbness, or limb
weakness.
Statistical Analysis. PASW Statistics 18 (SPSS Inc.,
Chicago, Illinois) was used for analyzing data after
importing the cleaned Excel data into SPSS. A t-
test for 2 group-comparisons was used for continu-
ous measures.
Chi-square tests were performed to examine
the relationship between categorical variables, for
example, patients’ medication usage (on aspirin or
not) and the clinical findings (likelihood of devel-
oping paraspinal hematomas, yes or no). A P value
of < 0.05 was considered significant in all analyses.
RESULTS
The population consisted of 25 (46.3%) men and
29 (53.7%) women with a mean age of 62.4 6 5.7
years for men and 62.7 6 8.1 years for women. A
total of 54 MRIs were reviewed. Twenty-nine of the
MRIs were of subjects who had undergone EMG
with paraspinal mapping in the 7 days before their
respective MR scanning. The remaining 25 MRI
scans were performed on subjects who had not yet
had an EMG at the time of MRI scanning.
Two MRIs demonstrated definite evidence of
paraspinal hematoma, while 10 were found to
have possible hematomas (Table 1). Six of the
possible hematomas were found in patients who
had undergone recent EMG, and 6 of the definite
or possible hematomas were discovered in
patients who had not yet undergone EMG. No
subject had more than 2 regions suspicious for ab-
normality. We used t-tests and Chi-square tests to
examine the relationship between MRI evidence
of paraspinal hematomas and the timing of the
EMG, the use of aspirin or other NSAIDs, subject
demographics, response to pain measurements,
paraspinal mapping scores, and other clinical fac-
tors that might have affected hematoma forma-
tion (Table 2). No significant (P > 0.05) differen-
ces in these variables were observed between
subjects with paraspinal hematoma and those
without hematoma.
Table 1. Description of cases of hematoma.
Case Timing of MRI
Imaging features consistent
with hematoma Size and location
1 Before EMG Yes 14 mm, behind right L5/S1 facet
2 Before EMG Yes 8 mm, behind right L4 lamina
3 Before EMG Possible 8 mm, behind right L5 lamina
4 Before EMG Possible 2 mm, immediately behind and contiguous with
right L4/5 facet
5 Before EMG Possible 4 mm, behind degenerated left L4/5 facet joint
6 < 1 week after EMG Possible 5 mm, contiguous with and immediately behind
left L5/S1 facet
7 < 1 week after EMG Possible 8 mm, behind right L5 lysis defect
5 mm, behind left L5 lysis defect
8 < 1 week after EMG Possible 4 mm, behind right L4/5 facet
9 < 1 week after EMG Possible 3 mm, behind right L4/5 facet
3 mm, behind left L3/4 facet
10 < 1 week after EMG Possible 6 mm, behind right L2/3 facet joint
11 < 1 week after EMG Possible 5 mm, left paraspinous process, L4 level
12 < 1 week after EMG Possible 4 mm, behind right L4/5 facet








Age at study, year No 42 63.13 7.464 1.152 0.971 0.336
Definite/Possible 12 60.87 5.487 1.584
Paraspinal mapping score right side total No 42 4.00 8.094 1.249 0.651 0.518
Definite/Possible 12 2.42 4.122 1.190
Paraspinal mapping score left side total No 42 3.40 4.623 0.713 0.151 0.880
Definite/Possible 12 3.17 5.458 1.576
Paraspinal mapping score
tested/symptomatic side
No 42 3.95 6.541 1.009 1.142 0.259
Definite/Possible 12 1.75 2.137 0.617
Paraspinal mapping score not
tested/asymptomatic side
No 42 3.45 6.645 1.025 0.177 0.860
Definite/Possible 12 3.83 6.337 1.829
Body Mass Index No 42 29.79 5.362 0.827 0.347 0.730
Definite/Possible 12 30.39 4.892 1.412
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Seven subjects with no known history of clinical
spinal stenosis were found to have possible hema-
tomas. All of these subjects had their EMGs per-
formed within 1 week before MRI imaging. A
review of their subsequent medical records did not
reveal any documented history of pain or sensory
or motor deficits after the EMG, with an average
follow-up of 20.6 months (range, 11–31 months).
Five subjects with a known clinical history of spinal
stenosis were found to have definite or possible
hematomas. None of them had undergone paraspi-
nal electromyography at the time of their MRI
imaging.
DISCUSSION
With or without extensive needle electromyogra-
phy of the lumbar paraspinal muscles, significant
bleeding complications are uncommon. This study
indicates that the overall risk of definite or possi-
ble paraspinal hematoma formation does not cor-
relate with whether or not subjects had undergone
recent paraspinal electromyography, or whether
they were taking aspirin or other nonsteroidal anti-
inflammatory drugs (NSAIDS) (Table 3). Under-
scoring this is the observation that only 2 definite
hematomas were found in our series, and both
were small lesions in persons who had not had
EMGs at the time of the MRI. The etiology of
these 2 hematomas is unknown. These subjects
had not undergone recent epidural or facet injec-
tions or other procedures that cause local trauma
to the paraspinal muscles. Both subjects had a
known history of clinical spinal stenosis, however,
and this raises the question of whether stenosis
itself is a risk factor for subclinical paraspinal hem-
atomas. Neurogenic claudication appears to be the
consequence of venous congestion in the pelvic
veins and the Batson venous plexus.12 Perhaps ve-
nous hypertension coupled with traction on the
veins along the neural foramina leads to small ve-
nous tears. Whatever the cause, the finding of
hematomas in patients with no history of trauma
draws into question all previous studies concerning
this issue.
No hematomas, definite or possible, were > 15
mm in size, and none of them were located near
neural structures. None of the previously asymp-
tomatic subjects with possible hematomas subse-
quently presented to our medical system with new
pain or sensory or motor deficits after the proce-
dure. Although we found a relatively large number
of possible hematomas, it, therefore, is not likely
that any of the lesions in this series were clinically
significant. It is also important to note that,
because possible hematomas occurred equally in
subjects who had undergone recent paraspinal
EMG and those who had not, it is possible that
these fluid collections represent synovial joint fluid
from nearby degenerated facet joints rather than
blood.
Although we found no evidence that EMG of
the paraspinal muscles causes clinically significant
bleeding complications, a single case report to the
contrary could contradict this conclusion. However
no such case report exists in the literature.
There is a discrepancy between the findings of
this study and the large series published by
Gertken et al., in which no hematomas were found
in 370 MRI scans.6 In that series, a hematoma was
defined as subacute or acute blood products at the
approximate level of the EMG, but imaging charac-
teristics or minimum size of the hematoma were
not defined further. It is unknown whether the
radiologists who reviewed the images in this series
identified fluid collections similar to those we
found in our study, or whether they discounted
them for being too small or inconsistent with
blood products. Both the Gertken study and ours
include a similar T1-weighted imaging technique,
but they did not perform the more sensitive sagit-
tal fat-saturated T2-weighted scans as part of their
routine protocol. Furthermore, they performed
Table 3. Comparative risk of hematoma in subgroups.
Variables N
Definite or possible
hematoma Chi square P value
Recent EMG 29 6 0.085 0.770
No recent EMG 25 6
Clinical spinal stenosis 24 5 0.048 0.826
No clinical spinal stenosis 30 7
Taking aspirin 16 3 0.159 0.690
Not taking aspirin 38 9
Recent EMG and aspirin 8 1 0.452 0.502
Recent EMG and no aspirin 21 5
Taking other NSAID 24 6 0.193 0.661
Not taking other NSAID 30 6
Recent EMG and other NSAID 10 3 0.806 0.309
Recent EMG and no other NSAID 19 3
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thicker axial sections with a large ‘‘gap’’ between
axial sections (5 mm axial sections with 5 mm
between sections), which would result in a lower
sensitivity for detecting smaller lesions.
There are a few potential limitations of our
study. Sixteen of the 54 subjects in this study had
MRI scans within 24 h after the EMG study. While
unlikely, it is possible that traumatic sequelae were
missed in this population, as a hematoma might
not have fully formed at the time the MRI scan
was performed.
Chart review suggested that previously asymp-
tomatic subjects with possible hematoma on MRI
did not report any new pain, sensory loss, or motor
deficits in the lower extremities following their
EMGs. However, it is possible that the hematomas
were symptomatic, and that the subjects did not
seek medical attention, or they sought medical
attention from a provider outside of the University
of Michigan system, and we were therefore unable
to review the pertinent records. We did not attempt
to perform a chart review on subjects with known
stenosis, because it may be difficult to discriminate
between pre-existing symptoms and new symptoms
referable to a paraspinal hematoma. Therefore, it is
possible that the subjects in this group were, in fact,
symptomatic from their small hematomas.
The paraspinal mapping technique used in this
study is performed using a 28-gauge monopolar
needle. Many electrodiagnostic physicians choose
to examine the paraspinal muscles with a concen-
tric needle electrode. These are usually slightly
larger (26 gauge) and may theoretically carry a
higher risk of bleeding.
Paraspinal electromyography including the par-
aspinal mapping technique can be considered safe
in the general population and in those taking non-
steroidal anti-inflammatory drugs. This study does
not address the safety of paraspinal needle exami-
nation in patients who are receiving therapeutic
anticoagulation. Given the diagnostic importance
of the paraspinal muscles in the evaluation of com-
mon neuromuscular disorders and the high fre-
quency of anticoagulation usage, a study of needle
electromyography on therapeutically anticoagu-
lated patients should be undertaken.13
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